MANKIND PHARMA
|
The Current P/S Ratio of MANKIND PHARMA is 8.13.
Share Price | ₹2,553.3 | Aug 06,2025 |
Market Cap | ₹105,372.6 Cr | |
Sales-TTM | ₹12,956.2 Cr | TTM-Consolidated Results |
Price/Sales | 8.13x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of MANKIND PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹105,372.6 Cr] as on Aug 06,2025
(/) Sales [ ₹12,956.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 8.13x ]
Thus, for MANKIND PHARMA , the investors are currently willing to pay '8.13 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of MANKIND PHARMA !
The chart below summarizes the trend in P/S Ratio of MANKIND PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of MANKIND PHARMA
PS Ratio Performance Analysis for MANKIND PHARMA
- MANKIND PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.43x.
- MANKIND PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MANKIND PHARMA 's p/e ratio peaked in Mar2024 at 8.97x.
- MANKIND PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does MANKIND PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
MANKIND PHARMA | 12,956.2 | 8.13 | 105,372.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.11 | 382,478.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 17.40 | 162,845.0 |
CIPLA LTD | 27,811.2 | 4.32 | 120,121.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.08 | 119,327.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 2.98 | 99,907.8 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.04 | 93,881.6 |
LUPIN LTD | 22,707.9 | 3.72 | 84,571.3 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.95 | 62,308.4 |
ABBOTT INDIA LTD | 6,409.2 | 10.81 | 69,302.6 |
ALKEM LABORATORIES LTD | 12,964.5 | 4.50 | 58,295.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MANKIND PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.95x |
Max industry PS | 17.40x |
Median industry PS | 4.50x |
Average industry PS | 6.82x |
You may also like the below Video Courses